ATHA Live signaler | Maksimer profitt med Getagraph.com

SELG 114907 min ago

@ $3.22

Utstedt: 14 feb 2024 @ 15:30

Avkastning: -39.13%

Forrige signal: feb 13 - 15:30

Forrige signal: Kjøp

Avkastning: 1.26 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation...

Stats
Dagens volum	147 921
Gjennomsnittsvolum	350 266
Markedsverdi	75.12M
EPS	$0 ( 2024-03-28 )
Neste inntjeningsdato	( $-0.800 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.630
ATR14	$0.00500 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-15	San Martin Javier	Buy	400 000	Stock Option (Right to Buy)
2024-04-15	San Martin Javier	Buy	0
2024-02-15	Litton Mark James	Buy	650 000	Stock Option (Right to Buy)
2024-02-14	Worthington Mark	Buy	220 000	Stock Option (Right to Buy)
2024-02-14	Church Kevin	Buy	220 000	Stock Option (Right to Buy)

INSIDER POWER
98.61
Last 99 transactions
Buy: 6 665 546 \| Sell: 65 252

Volum Korrelasjon

Lang: -0.06 (neutral)

Kort: -0.63 (weak negative)

Signal:(46.827) Neutral

Athira Pharma, Inc. Korrelasjon

10 Mest positive korrelasjoner
XERS	0.9
SGBX	0.898
VNET	0.893
SRTS	0.888
ABST	0.885
CNDT	0.883
RYTM	0.883
XENE	0.882
FREQ	0.882
WDAY	0.88

10 Mest negative korrelasjoner
RDUS	-0.883
TLMD	-0.879
CRWD	-0.879
LVO	-0.878
TYHT	-0.877
ICON	-0.873
ZGNX	-0.873
PAE	-0.873
PETV	-0.869
GOODM	-0.868

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Athira Pharma, Inc. Korrelasjon - Valuta/Råvare

0.43
( neutral )

0.38
( neutral )

0.00
( neutral )

0.29
( neutral )

0.00
( neutral )

-0.39
( neutral )

Athira Pharma, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-969 000 (0.00 %)
EPS:	$-3.09

FY	2023
Omsetning:	$0
Bruttogevinst:	$-969 000 (0.00 %)
EPS:	$-3.09

FY	2022
Omsetning:	$0
Bruttogevinst:	$-1.05M (0.00 %)
EPS:	$-2.31

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-4.58

Financial Reports:

No articles found.

Athira Pharma, Inc.

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.

Sanntidsoppdatering for Athira Pharma, Inc. [ATHA]

Upcoming Earnings Alert